| Sept. 18, 2012 |
Stephen Howell, MD
UCSD Hem/Onc |
Introduction to Cancer Therapeutics Development |
| Sept. 25, 2012 |
Michael Jackson, PhD
Sanford Burnham |
Discovery: high throughput screening for new drugs |
| Oct. 2, 2012 |
David Cheresh, PhD
UCSD |
Targeting a non-canonical β3 integrin signaling axis reverses cancer stemness and resistance to EGFR inhibitors |
| Oct. 9, 2012 |
Hong Xin, PhD
Explora Biolabs |
Cancer Drug Development and Pharmacokinetics |
| Oct. 16, 2012 |
Marque Todd, PhD
Pfizer |
Principles of cancer drug toxicology
|
|
Oct. 23, 2012
|
Olivier Harismendy, PhD
UCSD
|
Translating genomic profiling into personalized cancer care
|
|
Oct. 30, 2012
|
Alice Yu, MD
UCSD/Optimer Biotechnology
|
Treatment of breast cancer by targeting globo H
|
|
Nov. 6, 2012
|
Erin Reid, MD
UCSD
|
The discovery and development of brentuximab vedotin
|
|
Nov. 13, 2012
|
Anjana Rao, PhD
La Jolla Institute for
Allergy and Immunology
|
TET proteins and 5-hydroxymethylcytosine in cancer
|
|
Nov. 20, 2012
|
Michael Bouvet, MD
UCSD
|
Fluorescence imaging in mouse models of cancer
|
|
Monday
Nov. 26, 2012
|
Thomas Kipps, MD
UCSD
|
The Mouse That ROR'ed
|
|
Dec. 4, 2012
|
Bill Fenical, PhD
UCSD
|
Marine Microbial Metabolites Provide Access to New Protein Targets for the Treatment of Cancer
|
| Dec. 11, 2012 |
Scott Lippman, MD
UCSD |
MCC Becoming Regional Academia-Industry Hub for Translating Discovery and Biomedical Invention to the Clinic |
| Dec. 18, 2012 |
William Rice, PhD
Cylene Pharmaceuticals |
TBA |
| Jan. 8, 2013 |
Sandy Shattil, MD
UCSD |
Integrin Signaling: Biomarkers and Therapeutic Targets in Neoplasia |
| Jan. 15, 2013 |
Fred De Sauvage
Genentech |
Targeting the Hedgehog Pathway in Cancer: From Bench to Clinic |
| Jan. 22, 2013 |
Andrew McCammon
UCSD |
Structure-based, Computer-aided Drug Discovery |
| Feb. 19, 2013 |
Geoff Wahl, PhD
Salk Institute |
Investigating Breast Cancer from a Developmental Perspective |
| March 19, 2013 |
Patrick Vincent, PhD
Takeda |
Opportunities, Risks, and Strategy of a Fast Follower Drug Discovery Program: Design and Development of MEK Inhibitors |
| April 16, 2013 |
Francis Burrows
Tragara |
Who (And How) Do You Give the Drug With Everything? Developing a Multikinase Inhibitor for Cancer |
| May 21, 2013 |
Dietmar Berger
Genentech |
TBA |
| June 11, 2013 |
Gregory Reyes
Celgene |
TBA |